XML 430 R34.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Share-based payments | 12 Months Ended
--- | ---
Jun. 30, 2022
Share-based payments |
Share-based payments |
28 | Share-based payments
The Company operates a share-based award plan, the 2012 Equity Incentive Award Plan (the “Equity Plan”), established in 2012. Under the Equity Plan, 16,000,000 Class A ordinary shares have initially been reserved for issuance pursuant to a variety of share-based awards, including share options, share appreciation rights, or SARs, restricted share awards, restricted share unit awards, deferred share awards, deferred share unit awards, dividend equivalent awards, share payment awards and other share-based awards. Of these reserved shares, 14,788,222 remain available for issuance. Certain directors, members of executive management and selected employees have been awarded Class A ordinary shares, pursuant to the Equity Plan. These shares are subject to varying vesting schedules over multi-year periods. Employees are not entitled to dividends until the awards vest. The fair value of these shares was the quoted market price on the date of award, adjusted where applicable for expected dividends i.e. the fair value of the awards was reduced. It is assumed that semi-annual dividends will be paid for the foreseeable future. The Company may choose whether to settle the awards wholly in shares or reduce the number of shares awarded by a value equal to the recipient’s liability to any income tax and social security contributions that would arise if all the shares due to vest had vested. Accordingly, the awards may be either equity-settled or cash-settled. Movements in the number of share awards outstanding and therefore potentially issuable as new shares are as follows: ​
​ | ​ | ​ | ​ | ​
​ | ​ | Number of Class A ordinary shares
​ |  | Gross award |  | Post net settlement
At 1 July 2021 |  | 373,973 | ​ | 199,062
Awarded |  | 233,399 | ​ | 98,888
Vested |  | (166,215) | ​ | (67,659)
Forfeited |  | (72,723) | ​ | (38,240)
At 30 June 2022 |  | 368,434 | ​ | 192,051
​ The fair value of the shares awarded during the year was $10.59 (£8.72) (2021: $14.66 (£10.61)) per share. For the year ended 30 June 2022, the Group recognized total expenses related to equity-settled share-based payment transactions of £198,000 (2021: £1,386,000; 2020: £818,000) and total expenses related to cash-settled share-based payment transactions of £828,000 (2021: £616,000; 2020: £617,000).

X
- Definition The entire disclosure for share-based payment arrangements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 44 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration